Review
Topical minoxidil: review of efficacy and safety
Affiliations
- PMID: 2644080
Item in Clipboard
Review
Topical minoxidil: review of efficacy and safety
Cutis.
1989 Jan.
Abstract
Topical minoxidil (Rogaine) has recently been approved by the Food and Drug Administration for treatment of androgenetic alopecia. It has been approved for such use in many other countries. This paper is a review and summary of the reported efficacy and safety of topical minoxidil in the treatment of androgenetic alopecia. The results of anecdotal and controlled clinical trials are included. Realistic appraisal of the restorative and/or preventative potentials of topical minoxidil in androgenetic alopecia is needed.
Similar articles
-
Topical minoxidil therapy for androgenetic alopecia. A 30-month study.Arch Dermatol. 1987 Nov;123(11):1483-7. Arch Dermatol. 1987. PMID: 3314717 Clinical Trial.
-
Sulfotransferase activity in plucked hair follicles predicts response to topical minoxidil in the treatment of female androgenetic alopecia.Dermatol Ther. 2014 Jul-Aug;27(4):252-4. doi: 10.1111/dth.12130. Epub 2014 Apr 28. Dermatol Ther. 2014. PMID: 24773771 Clinical Trial.
-
A multicenter, randomized, placebo-controlled, double-blind clinical trial of a novel formulation of 5% minoxidil topical foam versus placebo in the treatment of androgenetic alopecia in men.J Am Acad Dermatol. 2007 Nov;57(5):767-74. doi: 10.1016/j.jaad.2007.04.012. Epub 2007 Aug 29. J Am Acad Dermatol. 2007. PMID: 17761356 Clinical Trial.
-
Androgenetic alopecia: an evidence-based treatment update.Am J Clin Dermatol. 2014 Jul;15(3):217-30. doi: 10.1007/s40257-014-0077-5. Am J Clin Dermatol. 2014. PMID: 24848508 Review.
-
Topical minoxidil therapy for hair regrowth.Clin Pharm. 1987 May;6(5):386-92. Clin Pharm. 1987. PMID: 3311578 Review.
Cited by
-
Intellectual property law: a primer for scientists.Mol Biotechnol. 2003 Mar;23(3):213-24. doi: 10.1385/MB:23:3:213. Mol Biotechnol. 2003. PMID: 12665692 Review.